Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Arabella Mazzocchi
Observed names:
A Mazzocchi,
A. MAZZOCCHI,
A. Mazzocchi
Institution:
Fondazione IRCCS Istituto Nazionale dei Tumori
Observed institutions:
National Institutes of Health,
National Cancer Institute,
Fondazione IRCCS Istituto Nazionale dei Tumori,
Stanford University
ORCID:
0000-0003-2345-9802
Observed ORCID:
0000-0003-2345-9802
OpenAlex ID:
A5083523436
Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients.
1993
·
A Anichini
, C Maccalli
, et al.
·
The Journal of Experimental Medicine
·
184
PDF
Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells.
2001
·
C Castelli
, A M Ciupitu
, et al.
·
PubMed
·
182
Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
1986
·
D Taramelli
, G Fossati
, et al.
·
PubMed
·
113
Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interaction.
1989
·
A Anichini
, A Mazzocchi
, et al.
·
The Journal of Immunology
·
105
T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
1993
·
M Sensi
, S Salvi
, et al.
·
The Journal of Experimental Medicine
·
101
PDF
A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapy.
1999
·
L Rivoltini
, P Squarcina
, et al.
·
PubMed
·
100
Human Melanoma-Reactive CD4+ and CD8+ CTL Clones Resist Fas Ligand-Induced Apoptosis and Use Fas/Fas Ligand-Independent Mechanisms for Tumor Killing
1998
·
Licia Rivoltini
, Marina Radrizzani
, et al.
·
The Journal of Immunology
·
85
PDF
Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapy
1996
·
L Rivoltini
, D J Loftus
, et al.
·
The Journal of Immunology
·
84
The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles
1998
·
Daniela Pende
, Laura Accame
, et al.
·
European Journal of Immunology
·
71
Vaccination of Melanoma Patients with Interleukin 4 Gene-Transduced Allogeneic Melanoma Cells
1999
·
Flavio Arienti
, Filiberto Belli
, et al.
·
Human Gene Therapy
·
59
Identification of a Mutated Receptor-Like Protein Tyrosine Phosphatase κ as a Novel, Class II HLA-Restricted Melanoma Antigen
2003
·
Luisa Novellino
, Nicolina Renkvist
, et al.
·
The Journal of Immunology
·
54
Novel HLA-Cw8-Restricted T Cell Epitopes Derived from Tyrosinase-Related Protein-2 and gp100 Melanoma Antigens
1999
·
Chiara Castelli
, Paolo Tarsini
, et al.
·
The Journal of Immunology
·
54
Frequency of cytotoxic T lymphocyte precursors (CTLp) interacting with autologous tumor via the T‐cell receptor: Limiting dilution analysis of specific CTLp in peripheral blood and tumor‐invaded lymph nodes of melanoma patients
1994
·
Arabella Mazzocchi
, Filiberto Belli
, et al.
·
International Journal of Cancer
·
50
Differences in Frequency Distribution of HLA-A2 Subtypes Between North American and Italian White Melanoma Patients: Relevance for Epitope Specific Vaccination Protocols
1996
·
Mary Anne Player
, Kathleen C Barracchini
, et al.
·
Journal of Immunotherapy
·
47
Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a non-endemic area
2017
·
Salvatore Alfieri
, Nicola Alessandro Iacovelli
, et al.
·
Oncotarget
·
41
PDF
Early reduction of serum TARC levels may predict for success of ABVD as frontline treatment in patients with Hodgkin Lymphoma
2017
·
A. Guidetti
, A. Mazzocchi
, et al.
·
Leukemia Research
·
28
Type I consensus interferon (CIFN) gene transfer into human melanoma cells up-regulates p53 and enhances cisplatin-induced apoptosis: implications for new therapeutic strategies with IFN-alpha
2000
·
M Mecchia
, P Matarrese
, et al.
·
Gene Therapy
·
28
Multiple melanoma-associated epitopes recognized by HLA-A3-restricted CTLs and shared by melanomas but not melanocytes
1996
·
A Mazzocchi
, W J Storkus
, et al.
·
The Journal of Immunology
·
26
Biological quality control for extracorporeal photochemotherapy: Assessing mononuclear cell apoptosis levels in ECP bags of chronic GvHD patients
2014
·
Francesca Taverna
, Paola Coluccia
, et al.
·
Journal of Clinical Apheresis
·
24
Shear-Induced Encapsulation into Red Blood Cells: A New Microfluidic Approach to Drug Delivery
2019
·
Monica Piergiovanni
, Giustina Casagrande
, et al.
·
Annals of Biomedical Engineering
·
22
PDF
Early serum TARC reduction predicts prognosis in advanced‐stage Hodgkin lymphoma patients treated with a PET ‐adapted strategy
2020
·
Simonetta Viviani
, Arabella Mazzocchi
, et al.
·
Hematological Oncology
·
20
PDF
Late onset of hepatitis B virus reactivation following hematopoietic stem cell transplantation: successful treatment with combined entecavir plus tenofovir therapy
2011
·
L. Milazzo
, M. Corbellino
, et al.
·
Transplant Infectious Disease
·
20
Human Lymphocyte Activation Gene-3 Molecules Expressed by Activated T Cells Deliver Costimulation Signal for Dendritic Cell Activation
2008
·
Chiara Casati
, Chiara Camisaschi
, et al.
·
The Journal of Immunology
·
19
T lymphocytes can mediate lysis of autologous melanoma cells by multiple mechanisms: Evidence with a single T cell clone
1990
·
Arabella Mazzocchi
, Andrea Anichini
, et al.
·
Cancer Immunology Immunotherapy
·
19
Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cells to be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytes
2001
·
Arabella Mazzocchi
, Cecilia Melani
, et al.
·
Cancer Immunology Immunotherapy
·
18
Show more works
View as search
Works count:
69
Citation count:
1,744
H-index:
20
I10-index:
35
Year
Topic
Type